# Pharmacokinetics of JULUCA in Hemodialysis

> **NCT04431518** · PHASE4 · COMPLETED · sponsor: **Indiana University** · enrollment: 8 (actual)

## Conditions studied

- HIV/AIDS
- ESRD

## Interventions

- **DRUG:** JULUCA 50Mg-25Mg Tablet

## Key facts

- **NCT ID:** NCT04431518
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-23
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04431518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04431518, "Pharmacokinetics of JULUCA in Hemodialysis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04431518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*